Abstract
Renal transplant recipients (RTRs) and patients with nondialysis chronic kidney disease display elevated circulating microparticle (MP) counts, while RTRs display immunosuppression-induced infection susceptibility. The impact of aerobic exercise on circulating immune cells and MPs is unknown in RTRs. Fifteen RTRs [age: 52.8 ± 14.5 yr, estimated glomerular filtration rate (eGFR): 51.7 ± 19.8 mL·min-1·1.73 m-2 (mean ± SD)] and 16 patients with nondialysis chronic kidney disease (age: 54.8 ± 16.3 yr, eGFR: 61.9 ± 21.0 mL·min-1·1.73 m-2, acting as a uremic control group), and 16 healthy control participants (age: 52.2 ± 16.2 yr, eGFR: 85.6 ± 6.1 mL·min-1·1.73 m-2) completed 20 min of walking at 60-70% peak O2 consumption. Venous blood samples were taken preexercise, postexercise, and 1 h postexercise. Leukocytes and MPs were assessed using flow cytometry. Exercise increased classical (P = 0.001) and nonclassical (P = 0.002) monocyte subset proportions but decreased the intermediate subset (P < 0.001) in all groups. Exercise also decreased the percentage of platelet-derived MPs that expressed tissue factor in all groups (P = 0.01), although no other exercise-dependent effects were observed. The exercise-induced reduction in intermediate monocyte percentage suggests an anti-inflammatory effect, although this requires further investigation. The reduction in the percentage of tissue factor-positive platelet-derived MPs suggests reduced prothrombotic potential, although further functional assays are required. Exercise did not cause aberrant immune cell activation, suggesting its safety from an immunological standpoint (ISRCTN38935454).
Highlights
Renal transplant recipients (RTRs) display an elevated cardiovascular disease (CVD) risk, attributed to both traditional and nontraditional risk factors [7, 24]
Fifteen RTRs, sixteen patients with nondialysis chronic kidney disease (ND-CKD), and sixteen healthy control (HC) participated in the study (Table 1)
Platelet count was lower in RTRs than HCs and patients with ND-CKD (P Յ 0.001), resulting in a value below the platelet reference range (RTRs: 55.18 ϫ 109 platelets/L, reference range: 150 – 450 ϫ 109 platelets/L) [38]
Summary
Renal transplant recipients (RTRs) display an elevated cardiovascular disease (CVD) risk, attributed to both traditional (e.g., hypertension and dyslipidemia) and nontraditional (e.g., chronic systemic inflammation) risk factors [7, 24]. More, RTRs display immunosuppression-induced infection susceptibility [2]. While patients with ND-CKD display impaired leukocyte function and altered subset distribution [43], immune function is further worsened in RTRs by immunosuppressive medication that inhibits T lymphocyte proliferation and function [18]. In RTRs, a fine balance must be struck concerning immunosuppression (undersuppression increases allograft rejection risk, whereas oversuppression increases infection susceptibility and malignancy risk), and so immune function must be closely monitored
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.